Supply Chain Intelligence

Oruka Therapeutics, Inc. Supply Chain

ORKA supply chain intelligence for Oruka Therapeutics, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

ORKA ·Last updated 2026-07-30 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

5Suppliers
2Customers
3Debt Items
20Related Chains

Oruka Therapeutics, Inc. Suppliers

TickerNameConfidenceEvidence
CMOS CMOS 92% we currently rely on CMOs to manufacture our product candidates
PARAGON PARAGON 90% Pursuant to the terms of each of the License Agreements, we are obligated to pay Paragon non-refundable milestone payments of up to $12.0 million under each respective agreement upon the achievement …
HALO Halozyme Therapeutics, Inc. 85% Reciprocal relationship from HALO graph: Reciprocal relationship from ORKA graph: Reciprocal relationship from HALO graph: Reciprocal relationship from ORKA graph: Reciprocal relationship from HALO g…
MLTX MoonLake Immunotherapeutics 72% ant to license agreements with Paragon. If the patent applications mature into one or more issued patents covering ORKA-001 or ORKA-002, we would expect those patents to expire in 2045, absent any ap…
MLTX MoonLake Immunotherapeutics 72% Reciprocal relationship from MLTX graph: Reciprocal relationship from ORKA graph: ant to license agreements with Paragon. If the patent applications mature into one or more issued patents covering OR…

Oruka Therapeutics, Inc. Customers

TickerNameConfidenceEvidence
MLTX MoonLake Immunotherapeutics 72% ant to license agreements with Paragon. If the patent applications mature into one or more issued patents covering ORKA-001 or ORKA-002, we would expect those patents to expire in 2045, absent any ap…
MLTX MoonLake Immunotherapeutics 72% Reciprocal relationship from MLTX graph: Reciprocal relationship from ORKA graph: Reciprocal relationship from MLTX graph: Reciprocal relationship from ORKA graph: ant to license agreements with Para…

Oruka Therapeutics, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
ORKA-DEBT Debt stack $1.8M 90% Market cache reports total debt of $1.8M.
ORKA-DEBT-11592 Xbrl Convertible 90% xbrl convertible detail from xbrl 2024-12-31.
ORKA-DEBT-11591 Warrants outstanding: 315356 90% xbrl warrant detail from xbrl 2025-12-31.

Oruka Therapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Oruka Therapeutics, Inc..

Oruka Therapeutics, Inc. Ownership

HolderNameConfidenceEvidence
ORKA-OWNER-FMR-LLC FMR LLC 90% 13F overlay lists FMR LLC as top holder; 188 tracked holders.

Oruka Therapeutics, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
ATOS Atossa Therapeutics, Inc. 100.00 2
CALC CalciMedica, Inc. 100.00 2
BLRX BioLineRx Ltd. 100.00 2
CTMX CytomX Therapeutics, Inc. 100.00 2
ALXO ALX Oncology Holdings Inc. 100.00 2
REGN Regeneron Pharmaceuticals, Inc. 100.00 2
ANRO Alto Neuroscience, Inc. 100.00 2
WHWK Whitehawk Therapeutics, Inc. 100.00 2
BIOA BioAge Labs, Inc. 100.00 2
CYTK Cytokinetics, Incorporated 100.00 2
CBIO Crescent Biopharma, Inc. 100.00 2
ANL Adlai Nortye Ltd. 100.00 2
CLYM Climb Bio, Inc. 100.00 2
CCEP Coca-Cola Europacific Partners PLC 100.00 2
DSGN Design Therapeutics, Inc. 100.00 2
AZN AstraZeneca PLC 100.00 2
CYTOF Altamira Therapeutics Ltd. 100.00 2
DBVTF DBV TECHNOLOGIES 100.00 2
EDIT Editas Medicine, Inc. 100.00 2
AMPH Amphastar Pharmaceuticals, Inc. 100.00 2
View ORKA supply chain intel →

Explore the full interactive supply chain map for Oruka Therapeutics, Inc..

Open ORKA supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map